Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
108.65
-18.93 (-14.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
108.00
-0.65 (-0.60%)
Bozor oldidan: May 13, 2026, 8:30 AM EDT
Inhibrx Biosciences, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, hayot uchun xavfli kasalliklarga chalingan odamlar uchun biologik dorilarni ishlab chiqish bilan shug'ullanadi. Uning terapevtik nomzodlari orasida 1-bosqichda bo'lgan INBRX-109, operatsiya qilinmaydigan yoki metastatik an'anaviy xondrosarkomani davolash uchun o'lim retseptoriga 5 ni nishonga olgan tetravalent terapevtik nomzod; va metastatik qattiq o'simta, mayda hujayrali bo'lmagan o'pka saratoni, melanoma, bosh va bo'yin mayda hujayrali o'pka saratoni, oshqozon yoki oshqozon-esofageal birikma adenokarsinomasi, buyrak hujayrali karsinoma va urotelial karsinoma davolash uchun OX4 ni nishonga olgan geksavalent sdAb-asosli terapevtik nomzod INBRX-106 mavjud. Inhibrx Biosciences, Inc. 2024 yilda tashkil etilgan va La Jolla, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ashraf Amanullah Ph.D. | Executive VP & Chief Technical Operations Officer |
| Dr. Carlos Bais Ph.D. | EVP & Chief Scientific Officer |
| Dr. Josep Garcia Ph.D. | Executive VP & Chief Clinical Development Officer |
| Mr. David J. Matly M.B.A. | President |
| Mr. Mark Paul Lappe | Founder, CEO & Chairman |
| Ms. Bonne Adams M.B.A. | Vice President of Operations |
| Ms. Kate Burke CPA, M.B.A. | Vice President of Accounting |
| Ms. Kelly Devine Deck B.S., CPA, M.S. | Executive VP, CFO & Treasurer |
| Ms. Leah Pollema J.D. | VP, General Counsel & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 8-K | inhibrx-20260511.htm |
| 2026-04-23 | DEFA14A | inbx2026additionalproxymat.htm |
| 2026-04-21 | 8-K | inhibrx-20260421.htm |
| 2026-03-19 | 8-K | inhibrx-20260319.htm |
| 2026-02-23 | 8-K | inhibrx-20260223.htm |
| 2025-12-16 | 8-K | inhibrx-20251216.htm |
| 2025-11-14 | 8-K | inhibrx-20251114.htm |
| 2025-10-23 | 8-K | inhibrx-20251023.htm |
| 2025-08-13 | 8-K | inhibrx-20250813.htm |
| 2025-06-02 | POS AM | inbx-posam3filing06022025.htm |